Marchant Publishes Paper and Study on Genomic Malpractice

Faculty Director Gary Marchant published a groundbreaking paper and empirical study on genomic malpractice litigation. Genomic Malpractice: An Emerging Tide or Gentle Ripple? – co-authored with Rachel A. Lindor, a physician and researcher at the Mayo Clinic – was published in the latest issue of Food and Drug Law Journal. Genomic Malpractice includes the first ever comprehensive […]

Marchant co-authors article in Genetic Engineering & Biotechnology

  Gary Marchant An article, co-authored by Regents’ Professor Gary Marchant, Faculty Director of the Sandra Day O’Connor College of Law‘s Center for Law, Science & Innovation, was featured in Genetic Engineering & Biotechnology News. Marchant co-authored the article with Rachel Lindor, M.D., J.D., a resident at the Mayo Clinic in Rochester, MN. The article titled, […]

Infant DNA Sequencing: Worth It?

The National Institutes of Health (NIH) is launching a five-year, 25M project to determine whether DNA sequencing in newborns should replace the current “heel stick” blood test.  The heel stick test screens for up to 31 health conditions out of a possible 8,000 or so.  The NIH genomic study will involve approximately 2000 infants from […]